Concern Over Temporary Bruise on My 3-Month-Old
Hello everyone! I wanted to share an experience with my 3-month-old daughter. Recently, while my dad was holding her right after they had been in the pool, I observed a mark on her skin that looked like a bruise. It appeared quite dark initially but then faded away within a few minutes. In addition, she seems to be more irritable over the past couple of days. However, I suspect this might be due to a nursing strike, as she's been able to take a bottle with pumped milk without any issues. She’s sleeping normally, displaying no signs of lethargy, but her fussiness has noticeably increased. Should I be worried about this bruise-like mark, especially since it seemed to vanish so quickly?
Answers (1)
7/19/2025, 10:20:30 PM
OpenHealth AI
It’s understandable to be concerned about any mark on your baby, especially when it looks like a bruise. Based on your description, it sounds like the mark faded quickly, which is encouraging and might suggest it was a temporary issue, possibly from a minor impact. However, increased irritability can be concerning, even if you suspect it’s related to feeding.
Explanation: Bruises in infants can occur from minor bumps and are usually not a cause for alarm, especially if they resolve quickly and the baby is otherwise behaving normally. The fact that she is sleeping well and shows no lethargy is also reassuring. Irregular behavior, such as increased fussiness, can be linked to various factors, including teething, developmental changes, or temporary feeding issues.
Next Steps:
- Monitor the Mark: Keep an eye on the bruise-like mark for any changes. If it reappears or if other unusual marks develop, or if you notice any swelling, further assessment may be warranted.
- Track Behaviors: Observe your daughter’s irritability over the next few days. If she continues to be fussy and you notice other concerning symptoms (like difficulty feeding, changes in her sleep patterns, or signs of pain), that would be important to consider.
- Check Feeding: Since you mentioned a nursing strike, ensure she’s still getting enough nourishment. If her fussiness is tied to feeding, consider different positions or environments for bottle-feeding to make it more comfortable for her.
If you're uncertain or if her condition changes noticeably, reaching out to a healthcare professional would provide you with peace of mind. Your observations and instincts as a parent are very important, so trust your judgment in watching her closely.
Related Questions
Understanding My Health Concerns
I'm a 22-year-old individual with a tall, slender physique but carry a bit of excess fat. I possess wide hips indicating a unique fat distribution typical in females. Interestingly, I don't have any facial or chest hair, and although my voice is somewhat soft, I did experience a shift during puberty. My muscle mass appears to be low, and I have a youthful appearance with what I've noticed might be a reduction in the size of my testicles (though I'm unsure and could be mistaken). To clarify my situation, I underwent a testicular ultrasound, which provided the following results: the right testicle measures 1.7 cm by 2.4 cm by 4.1 cm, with an estimated volume of 8.7 cc. The left testicle is measured at 1.7 cm by 2.4 cm by 4 cm, and its estimated volume is 8.5 cc. Both testicles show slight variations in echogenicity without any focal lesions, and the blood supply appears normal on both sides. The epididymides are generally normal, except for a tiny cyst (0.2 cm) found on the left epididymal head. Notably, there are no signs of varicocele or hydrocele on either side. Additionally, I had several laboratory tests conducted, resulting in the following findings: - Total Testosterone: 20.26 (reference range: 1.63 to 34.00) compared to 23 eight months prior. - Free Testosterone: 36.32 (reference range: 77.83 to 16.69), which was also tested separately about eight months ago. - LH (Luteinizing Hormone): 5.12 (reference range: 0.57 to 12.07). - FSH (Follicle Stimulating Hormone): 3.72 (reference range: 0.95 to 11.95). - TSH (Thyroid Stimulating Hormone): 0.96 (reference range: 0.35 to 4.94). - Prolactin: 321.24 (reference range: 73 to 407). - Free T4: 15.47 (reference range: 9.00 to 19.00). Given these details, could I possibly have Klinefelter Syndrome or even present a mosaic pattern? I'm genuinely worried about my health and feel as though I am emotionally and physically stuck at an age of 15. Any insights or information would be greatly appreciated.
Choosing the Right Specialist for Eye Socket Concerns
About four weeks back, I (F28) suffered from a black eye due to an injury. Although the discoloration has faded, I am now worried about a possible fracture in the eye socket, particularly at the lower corner of my eyebrow. Currently, my vision is intact, but the area where I experienced the impact is still sensitive when touched, and I’m also experiencing some numbness. Additionally, there's a persistent hard bump near my eyelid that isn’t typical, and it retains a faint purplish hue, similar to a scar. I feel discomfort when moving my eyebrow and occasionally experience tingling and a pulsing sensation, roughly once a day. I intend to seek medical attention to prevent any vision complications that could arise if a fracture is present. I’d like to know which medical professional is best suited to address my concerns. Should I consult with an ophthalmologist, an orthopedic specialist, or perhaps someone else entirely?
Throat Discomfort
I am a 31-year-old male, standing 6 feet tall and weighing 140 pounds, and I've noticed an uncomfortable sore on one side of my tonsil that has persisted since the start of this week. The pain it causes is quite severe and has been disrupting my sleep at night. To alleviate some of the discomfort, I’ve been using a mouth rinse containing peroxide since I learned it could be beneficial, and it does provide temporary relief. Could this be a canker sore? Should I simply allow time for it to heal, or would it be better to seek medical attention?
Worsening Blood Cell Counts: A 45-Year-Old Woman's Journey
A 45-year-old woman, who does not smoke or drink, has been managing her blood pressure with medication, which has remained stable. After experiencing some weight gain following a COVID-19 infection, she attempted to improve her health through dietary changes and increased physical activity, but struggled to lose weight. In May 2025, she began using Wegovy and successfully shed 15 pounds while continuing to refine her diet and exercise routine. Approximately two years ago, during her annual blood tests in June 2023, the results indicated elevated absolute Neutrophils and white blood cell (WBC) counts. Similar abnormalities had previously occurred during particularly stressful periods, which subsequently normalized once the stress was mitigated. In May of this year, follow-up tests revealed high platelet levels alongside elevated absolute Neutrophils. A more recent blood draw on July 15th showed concerning results, including increased Monocytes, Neutrophils, Erythrocytes, and Leukocytes, while Lymphocytes appeared low and RDW was high. Despite making an appointment with a hematologist for further evaluation, the earliest available date is in September. Given the recurring nature of these abnormalities in her blood work, she feels anxious about waiting for such a long period. She would greatly appreciate any insights or advice regarding her condition.
Management Strategies for Neuroendocrine Cancer Recurrence Following Surgical Intervention
Seeking expert medical insights on possible next steps for the following patient case. Next-Generation Sequencing (NGS) failed to identify any distinct markers, and the prior treatment involving neoadjuvant chemotherapy combined with immunotherapy (Cisplatin, Etoposide, and Durvalumab) led to a stabilized tumor, showing no further growth. Would administering Carboplatin, Irinotecan, and Durvalumab in a second-line capacity be an appropriate option? Are there alternative measures available to tackle the metastases present in multiple locations? Thank you! **Patient Profile:** **Age:** 68 years **Diagnosis:** Poorly Differentiated Neuroendocrine Carcinoma of the Gallbladder **Initial Diagnosis Date:** February 2025 # Surgical Background: - **Procedure Performed:** Extended cholecystectomy alongside duodenal and partial bowel resection (ileo-colic anastomosis) - **Surgery Date:** April 2025 - **Surgical Findings:** Gallbladder mass exhibiting infiltration into the liver and adjacent intestinal wall - **Postoperative Pathology (May 2025):** - **Tumor Type:** High-grade NEC with a Ki-67 proliferation index of approximately 55-60% - **Lymph Node Involvement:** ypN1 (1-2 nodes positive) - **Surgical Margins:** Clear - **Staging:** ypT4, ypN1 (AJCC 8th Edition, following treatment) # Immunohistochemistry (IHC) Analysis and Biomarkers: - **Synaptophysin:** Strong, widespread positivity - **Pan-CK:** Patchy positivity observed - **Others (Chromogranin, CK7, CK19, CDX2):** Negative - **INI-1:** Expression remains intact - **Ki-67 Index:** 55-60% - **PD-L1 (FoundationOne):** Tumor Proportion Score (TPS) at 25% - **Mismatch Repair (MMR):** Expression intact (not MSI-high) # Molecular Testing Results (FoundationOne CDx): - **Identified Pathogenic Variants:** TP53 and MYC amplification - **Tumor Mutational Burden (TMB):** Not elevated - **Microsatellite Instability (MSI):** Stable (not MSI-H) - **PD-L1 Expression:** 25% (supports the use of immune checkpoint inhibitors) # Treatment History Overview: - **First-Line Therapy (Feb-Apr 2025):** - **Regimen:** Cisplatin combined with Etoposide and Durvalumab (administered over 4 cycles) - **Response:** Limited effectiveness (no reduction in tumor size); progression noted in PET-CT imaging - **Surgical Intervention:** April 2025 (details as previously outlined) - **Postoperative Plan:** Monitoring alongside Durvalumab as maintenance therapy # Recent PET-CT Findings (July 2025): |Location|Outcome|SUV Max|Interpretation| |:-|:-|:-|:-| |Liver (Segment 5)|New FDG-avid lesion|25.3|Evidence of metastatic recurrence| |Gastroduodenal region|Nodular lesion|6.35|Indication of metastatic recurrence| |Ileocolic anastomosis area|Eccentric nodular lesion|3.03|Likely metastatic involvement| |Peritoneal cavity|Soft tissue deposition|21.07|New peritoneal metastasis detected| |Abdominal wall|FDG-avid lesion at umbilicus|13.67|Presence of cutaneous metastasis| |Other regions|No unusual uptake (brain, lungs, lymph nodes)|- |Absence of distant metastasis|